Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicTreatment OutcomeBone Marrow DiseasesRecurrenceKidney TransplantationCombined Modality TherapyHematopoiesisRadiation ChimeraMice, Inbred C57BLTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteImmunosuppressive AgentsRemission InductionHematologic NeoplasmsGraft RejectionHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyHeart TransplantationAcute DiseaseGraft vs Host ReactionLeukemia, MyeloidStem Cell TransplantationRetrospective StudiesImmunosuppressionLymphocyte DepletionLeukocyte TransfusionLymphoma, Non-HodgkinSurvival AnalysisFollow-Up StudiesSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayT-LymphocytesHLA AntigensMyelodysplastic SyndromesActuarial AnalysisLung TransplantationCyclosporineBone DensityHematologic DiseasesLymphocyte TransfusionSurvival RateNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCarmustineOrgan TransplantationPancytopeniaGraft vs Tumor EffectCell DifferentiationGraft vs Leukemia EffectCytarabineLeukocyte CountCytomegalovirus InfectionsPrognosisBone ResorptionDisease-Free SurvivalSpleenGranulocyte Colony-Stimulating FactorMelphalanMice, Inbred BALB CEtoposideFatal OutcomeFlow CytometryLymphomaMultiple MyelomaProspective StudiesCells, CulturedPostoperative ComplicationsAntigens, CD34Hodgkin DiseaseMice, KnockoutInfectionCell Transplantation